Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 8Genitourinary 6Thoracic 5Gastrointestinal 5Plasma cell 2Lymphoid 2Tumor-Agnostic 1Sarcoma 1NET 1Endocrine 1Classical hematology 1

Conditions

Multiple Myeloma 2Lymphoma, Non-Hodgkin 1Lymphoma 1Hodgkin Disease 1Agnosia 1

Interventions

Cyclophosphamide 342Rituximab 304Vincristine 157Doxorubicin 154venetoclax 153fludarabine 153Specimen Handling 152Prednisone 150Biopsy 122Magnetic Resonance Spectroscopy 117obinutuzumab 116Lenalidomide 109Dexamethasone 104Cytarabine 97ibrutinib 95Etoposide 92fludarabine phosphate 87Methotrexate 84acalabrutinib 78Bendamustine Hydrochloride 72zanubrutinib 71blinatumomab 63pembrolizumab 62CT-P10 60Gemcitabine 51Nivolumab 45glofitamab 44Calcium Dobesilate 44Mercaptopurine 43prednylidene 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Acupuncture Therapy × Lymphoid × 1 year × Clear all
NCT04459416 2025-10-20

Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 3 Active not recruiting
299 enrolled 11 charts
LymphoidPlasma cell

Agnosia, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed
51 enrolled 8 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡